Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2020 16:14 ET | Source: Kadmon Holdings, Inc.

Kadmon Highlights Recent Progress and Reports Fourth Quarter and Full Year 2019 Financial Results

NEW YORK, March 05, 2020 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today provided a business update and reported financial and operational results for the fourth quarter and full year...
February 11, 2019 16:15 ET | Source: Kadmon Holdings, Inc.

Kadmon Announces Appointment of Steven Meehan as CFO

NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today announced the appointment of Steven Meehan as Executive Vice President, Chief Financial Officer. Mr. Meehan, who...
February 07, 2019 16:15 ET | Source: Kadmon Holdings, Inc.

Kadmon Announces Appointment of David E. Cohen, M.D., MPH, to Board of Directors

NEW YORK, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today announced the appointment of David E. Cohen, M.D., MPH, to its Board of Directors. Dr. Cohen has held a variety...
January 23, 2019 16:15 ET | Source: Kadmon Holdings, Inc.

Kadmon Announces Appointment of Cynthia Schwalm to Board of Directors

NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today announced the appointment of Cynthia Schwalm to its Board of Directors. Ms. Schwalm has extensive pharmaceutical...
January 04, 2019 16:15 ET | Source: Kadmon Holdings, Inc.

Kadmon Announces Appointment of Tasos G. Konidaris as Interim Chairman of the Board

NEW YORK, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Tasos G. Konidaris, a member of Kadmon’s board of directors, has been appointed interim chairman,...
December 27, 2018 16:15 ET | Source: Kadmon Holdings, Inc.

Kadmon Chairman Bart M. Schwartz to Step Down from Board

NEW YORK, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Bart M. Schwartz, Esq. is stepping down as director and Chairman of the Board of Directors (the...
December 03, 2018 10:00 ET | Source: Kadmon Holdings, Inc.

Kadmon Announces Updated Findings from Ongoing Phase 2 Clinical Trial of KD025 in cGVHD at ASH Annual Meeting

NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today announced updated data from its ongoing Phase 2 clinical trial of KD025, its selective oral inhibitor of...
November 29, 2018 09:00 ET | Source: Kadmon Holdings, Inc.

Kadmon Presents Data on New ROCK Inhibitor Clinical Candidate at Anti-Fibrotic Drug Development Summit

NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today announced the presentation of preclinical data supporting the therapeutic potential of Rho-associated coiled-coil...
November 09, 2018 16:20 ET | Source: Kadmon Holdings, Inc.

Kadmon Provides Business Update and Reports Third Quarter 2018 Financial Results

NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today provided a business update and reported financial and operational results for the third quarter of 2018. “We...
November 07, 2018 09:00 ET | Source: Kadmon Holdings, Inc.

Kadmon to Present at the Jefferies 2018 London Healthcare Conference

NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at the Jefferies 2018...